Birth Control Options for Trans and Non-Binary People

Choosing appropriate contraception is an important aspect of reproductive healthcare that requires careful consideration of individual circumstances, medical history, and personal goals. For transgender and non-binary people, this decision involves additional factors related to gender-affirming care and ongoing hormone therapy. Understanding available options and how they interact with gender-affirming treatments empowers individuals to make informed choices aligned with their health needs and reproductive aspirations.

Understanding Reproductive Healthcare in Gender-Affirming Care

Reproductive capacity and contraceptive needs vary significantly among transgender and non-binary people based on their assigned sex at birth, current anatomy, and chosen gender-affirming interventions. Unlike cisgender populations where reproductive anatomy is typically consistent with gender identity, transgender and non-binary individuals may have diverse combinations of reproductive organs and hormone levels. Healthcare providers must recognize that each person’s situation is unique and requires individualized assessment rather than assumptions based on gender identity alone.

According to the American College of Obstetricians and Gynecologists (ACOG), transgender and non-binary individuals can access any contraceptive method available to cisgender women if medically appropriate and approved by their healthcare provider. This inclusive approach acknowledges that reproductive health is not determined by gender identity but by individual anatomy, hormone use, and reproductive goals. The absence of absolute contraindications to any contraceptive method for transgender and gender-diverse adolescents and young adults means that choices can be made based on personal preference, effectiveness, and compatibility with other medical treatments.

Progestin-Based Contraceptive Methods

Progestin-only contraceptives represent among the most flexible options for people undergoing testosterone therapy or other masculinizing hormone treatments. Unlike combination hormonal contraceptives containing estrogen, progestin-only methods do not interfere with testosterone effectiveness and maintain compatibility with gender-affirming care. These methods are particularly appealing to transgender men and non-binary people because they do not introduce estrogen—a hormone associated with feminizing effects—into the body.

Progestin-based options include several delivery mechanisms, each with distinct advantages:

• Oral progestin-only pills: Medications such as norethindrone acetate provide daily contraceptive coverage and can help reduce or eliminate menstrual bleeding, supporting individuals seeking menstrual suppression as part of their gender-affirming goals. These pills require consistent daily adherence but offer flexibility and easy discontinuation if pregnancy is desired.
• Injectable contraceptives: Medroxyprogesterone acetate (Depo-Provera) and intramuscular medroxyprogesterone deliver contraceptive protection through regular injections administered every three months. These longer-acting methods reduce the need for daily adherence and frequently result in amenorrhea—the cessation of menstrual periods—which many transgender and non-binary people find affirming.
• Implantable devices: The etonogestrel subdermal implant (Nexplanon, Implanon) provides three years of continuous contraceptive protection through a small rod inserted under the arm skin. This method offers high efficacy, does not require ongoing maintenance, and commonly results in menstrual suppression.
• Levonorgestrel intrauterine systems: These IUDs, including brands such as Mirena, Kyleena, and Liletta, release progestin directly into the reproductive tract while maintaining minimal systemic hormone absorption. This localized delivery makes them particularly suitable for individuals concerned about systemic hormone exposure while providing excellent contraceptive efficacy and menstrual management.

Long-acting reversible contraceptives (LARCs)—including implants and IUDs—offer particular advantages for individuals who have not yet made permanent decisions about their reproductive potential but seek extended protection without daily decision-making.

Combination Hormonal Contraceptives and Testosterone Therapy

Combination hormonal contraceptives, which contain both estrogen and progestin, present a more complex situation for individuals using testosterone as part of their gender-affirming care. Current evidence indicates no absolute contraindication to concurrent use of combination hormonal contraceptives and testosterone therapy, though individual preferences and concerns vary significantly.

Available combination hormonal methods include:

• Oral contraceptives: Pills containing ethinyl estradiol and various progestins, such as Yaz, Yasmin, and Loestrin, remain among the most commonly used reversible contraceptives. The estrogen doses in modern formulations are sufficiently low that they typically do not substantially interfere with testosterone effectiveness.
• Transdermal patches: Contraceptive patches deliver hormones through the skin and include formulations such as Xulane/Zafemy (containing norelgestromin and ethinyl estradiol) and Twirla (containing levonorgestrel and ethinyl estradiol). These methods eliminate daily pill-taking and provide consistent hormone delivery.
• Vaginal rings: Flexible rings inserted into the vagina release hormones directly into the reproductive tract. Examples include Nuvaring (containing etonogestrel and ethinyl estradiol) and Annovera (containing segesterone acetate and ethinyl estradiol). The local hormone delivery in these methods may result in lower systemic hormone exposure compared to oral pills.

Despite the absence of medical contraindications, some transgender individuals decline combination hormonal methods due to concerns about introducing estrogen into their bodies and worry about potential feminizing effects, such as breast tissue development or changes in body composition. Healthcare providers should discuss these preferences openly and consider alternative methods before recommending combination hormonal contraceptives.

Non-Hormonal Contraceptive Approaches

Non-hormonal contraceptive methods provide alternatives for individuals who prefer to avoid hormonal interventions or who have specific medical conditions precluding hormone use. These methods work through physical or chemical barriers rather than systemic hormone effects.

Barrier methods include external condoms, internal condoms, and diaphragms. Condoms offer the dual benefit of contraceptive protection and sexually transmitted infection (STI) prevention—a benefit unique among contraceptive options. External condoms are widely accessible without prescription and simple to use, though they require consistent application with each act of intercourse. Internal condoms, also called female condoms, are inserted into the vagina before intercourse and provide similar protection. Diaphragms cover the cervix and block sperm passage; they require professional fitting and must be used with spermicide.

Copper intrauterine devices represent the only non-hormonal LARC option. The copper IUD creates an inhospitable environment for sperm and fertilized eggs without releasing any hormones, making it suitable for individuals seeking to avoid all hormonal contraceptives. Copper IUDs provide protection for 10+ years and can be removed at any time if pregnancy is desired.

Non-hormonal methods appeal to some transgender individuals who perceive all hormonal contraceptives—whether estrogen, progestin, or both—as “female” hormones and prefer to avoid them entirely, though some individuals find progesterone-only methods more acceptable than combination options.

Emergency Contraception Options

Emergency contraception provides pregnancy prevention after unprotected intercourse or contraceptive failure. Multiple effective options exist with no contraindications for transgender and gender-diverse individuals.

Levonorgestrel emergency contraception (Plan B and generic equivalents) contains progestin and functions most effectively when taken within 72 hours of unprotected intercourse, though some effectiveness remains up to 120 hours. This over-the-counter medication requires no prescription and presents no hormonal conflicts with testosterone therapy.

Ulipristal acetate (Ella), a selective progesterone receptor modulator, provides emergency contraceptive effectiveness up to 120 hours after intercourse and may be more effective than levonorgestrel for individuals with higher body weight. This medication requires a prescription but offers extended efficacy compared to levonorgestrel.

Intrauterine device insertion for emergency contraception represents the most effective emergency method. Both copper and levonorgestrel IUDs prevent pregnancy when inserted within five days of unprotected intercourse and are more than 99% effective at preventing pregnancy. This approach converts emergency contraception into long-term pregnancy prevention.

Contraceptive Considerations for Transgender Women and Non-Binary People Assigned Male at Birth

Individuals with female gender identity or non-binary identities who were assigned male at birth and have penile anatomy face different contraceptive considerations than those with female reproductive anatomy. Feminizing hormone therapy—including estrogen and androgen blockers—does not reliably prevent sperm production or eliminate pregnancy risk if their partners have female reproductive anatomy.

Barrier method contraception through condom use represents the primary reversible option for this population. External condoms prevent both pregnancy and STI transmission when used consistently and correctly. If sexual partners do not want to become pregnant, they must use their own contraceptive methods in addition to condom use, as condoms alone are less effective than other contraceptive methods.

Permanent surgical options include vasectomy—a procedure blocking the vas deferens tubes to prevent sperm from reaching the ejaculate—and orchiectomy, which involves surgical removal of the testicles. These procedures provide highly effective, permanent pregnancy prevention for individuals certain about their reproductive goals.

Menstrual Suppression and Gender-Affirming Goals

Many transgender and non-binary people experience gender dysphoria related to menstruation, viewing it as inconsistent with their gender identity. Multiple contraceptive and non-contraceptive methods can suppress or eliminate menstrual bleeding, supporting both reproductive health and gender-affirming goals.

Hormonal contraceptives frequently result in amenorrhea—the complete cessation of menstrual periods. Progestin-only methods, particularly injections and implants, produce amenorrhea in high proportions of users. Some individuals use continuous combined oral contraceptives (pills taken without hormone-free intervals) or extended-cycle formulations such as Seasonale and Seasonique to suppress menstrual bleeding while using combination hormonal methods.

For individuals not using hormonal contraceptives, surgical options including uterine ablation (destruction of the uterine lining) and hysterectomy (surgical removal of the uterus) provide permanent menstrual suppression, though these represent irreversible decisions requiring careful consideration.

Choosing the Right Method: Personalized Decision-Making

Selecting appropriate contraception requires collaboration between individuals and healthcare providers who understand transgender and non-binary health. Key factors in this decision include:

• Current hormone therapy and compatibility concerns with specific contraceptive methods
• Reproductive goals and whether future pregnancy is desired or ruled out
• Preferences regarding menstrual suppression
• Comfort level with different contraceptive mechanisms and delivery routes
• Medical history and any contraindications to specific methods
• Frequency of sexual activity and number of partners (relevant for STI risk assessment)
• Practical considerations such as cost, access, and required maintenance

Healthcare providers should present all medically appropriate options without assumptions, recognize individual preferences as valid, and ensure informed decision-making processes that respect autonomy and reproductive goals.

Frequently Asked Questions

Can I use hormonal birth control while taking testosterone?

Yes. Progestin-only methods are fully compatible with testosterone therapy. Combination hormonal contraceptives containing estrogen do not have absolute contraindications to concurrent testosterone use, though individual comfort levels vary. Discussion with your healthcare provider can help identify options matching your preferences.

Will birth control interfere with my gender-affirming hormone therapy?

Progestin-only contraceptives do not interfere with testosterone. Combination hormonal contraceptives contain only small amounts of estrogen that typically do not substantially affect testosterone therapy effectiveness. However, if you have concerns about any hormonal interaction, discuss specific methods with your provider.

What’s the best method for menstrual suppression?

Progestin-only injections, implants, and levonorgestrel IUDs most reliably produce amenorrhea. Continuous-use combination hormonal contraceptives also suppress menstruation effectively. The best choice depends on your compatibility with each method and personal preferences.

Do I need birth control if I’m a transgender woman on estrogen?

Feminizing hormone therapy does not prevent pregnancy if you have vaginal sex with someone who can become pregnant and you ejaculate inside them. If you have not had a vasectomy or orchiectomy, your partner should use birth control, and condoms provide additional STI protection.

Are there any contraceptive methods I cannot use?

No. According to current medical evidence, transgender and non-binary individuals have no absolute contraindications to any contraceptive method. Your healthcare provider can help identify medically appropriate options matching your health status and preferences.